Panagora Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Buy
206,854
+128,518
+164% +$3.04M 0.02% 407
2025
Q4
$2.06M Sell
78,336
-27,736
-26% -$605K 0.01% 562
2025
Q3
$1.81M Buy
106,072
+72,513
+216% +$1.04M 0.01% 543
2025
Q2
$421K Buy
+33,559
New +$400K ﹤0.01% 843
2025
Q1
Sell
-214,338
Closed -$3.14M 1218
2024
Q4
$3.14M Buy
214,338
+113,472
+112% +$1.59M 0.01% 430
2024
Q3
$1.27M Buy
+100,866
New +$1.1M 0.01% 655

Other funds holding ZYME

Panagora Asset Management's ZYME Position: Q1 2026 in Review

Panagora Asset Management increased its Zymeworks (ZYME) stake by 164% in Q1 2026, buying an estimated $3.04M and bringing the position to 206,854 shares worth $5.18M. The position accounts for 0.02% of the portfolio, ranked #407.

Panagora Asset Management first reported a position in ZYME in Q3 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Panagora Asset Management held 206,854 shares of Zymeworks worth $5.18M as of Q1 2026.
  • Panagora Asset Management bought 128,518 Zymeworks shares in Q1 2026, an estimated $3.04M.
  • Zymeworks made up 0.02% of Panagora Asset Management's portfolio in Q1 2026, its #407 holding.
  • Panagora Asset Management first reported a position in Zymeworks in Q3 2024 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.